James Pickens Jr. from Grey’s Anatomy Raises Awareness About Early Cancer Screening
Grey’s Anatomy star James Pickens Jr. is shedding light on the importance of early cancer screening following a shocking revelation about his character, Dr. Richard Webber. In a recent interview with Black Health Matters, Pickens opened up about his own real-life battle with prostate cancer.
Discovering the Diagnosis
In the midseason finale of season 22 of Grey’s Anatomy, Webber, a long-standing character on the show, was diagnosed with cancer. Pickens revealed that he too was diagnosed with prostate cancer, sharing, «Prostate cancer has affected my family. My father and several of his brothers had it. I would have been surprised if I hadn’t received it.«
Early Detection and Treatment
Despite the hereditary nature of the disease in his family, Pickens emphasized the importance of regular testing. Thanks to his proactive approach, the actor, now 71, caught his cancer early through routine screenings. Following an elevated PSA level, an MRI revealed a concerning issue that led to the discovery of a tumor through a biopsy.
Fortunately, Pickens’ tumor had not spread, allowing for successful treatment. «We caught it very early, and they thought that would be the best route to take. They hadn’t seen any that were caught as early as mine,» he shared, highlighting the importance of early detection.
Advocating for Early Screening
In a video shared on his Instagram page, Pickens stressed the significance of early detection, especially for black men who face a higher risk of prostate cancer. He encouraged regular screenings starting at age 40, emphasizing that early detection can save lives.
«Today I am living proof that early detection works. If you are black or have a family history of prostate cancer, talk to your doctor about getting screened. For more information, visit blackhealthmatters.com.»
Looking Ahead
Grey’s Anatomy Season 22 will resume on January 6, 2025, as Pickens continues to raise awareness about the importance of early cancer screening and the impact it can have on saving lives.
